1. Home
  2. NLSP vs AHG Comparison

NLSP vs AHG Comparison

Compare NLSP & AHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • AHG
  • Stock Information
  • Founded
  • NLSP 2015
  • AHG 2013
  • Country
  • NLSP Switzerland
  • AHG China
  • Employees
  • NLSP N/A
  • AHG N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • AHG Business Services
  • Sector
  • NLSP Health Care
  • AHG Consumer Discretionary
  • Exchange
  • NLSP Nasdaq
  • AHG Nasdaq
  • Market Cap
  • NLSP 12.4M
  • AHG 765.9M
  • IPO Year
  • NLSP 2021
  • AHG N/A
  • Fundamental
  • Price
  • NLSP $2.10
  • AHG $1.82
  • Analyst Decision
  • NLSP
  • AHG
  • Analyst Count
  • NLSP 0
  • AHG 0
  • Target Price
  • NLSP N/A
  • AHG N/A
  • AVG Volume (30 Days)
  • NLSP 275.3K
  • AHG 64.1K
  • Earning Date
  • NLSP 07-22-2025
  • AHG 07-22-2025
  • Dividend Yield
  • NLSP N/A
  • AHG N/A
  • EPS Growth
  • NLSP N/A
  • AHG N/A
  • EPS
  • NLSP N/A
  • AHG N/A
  • Revenue
  • NLSP N/A
  • AHG $8,454,946.00
  • Revenue This Year
  • NLSP N/A
  • AHG N/A
  • Revenue Next Year
  • NLSP N/A
  • AHG N/A
  • P/E Ratio
  • NLSP N/A
  • AHG N/A
  • Revenue Growth
  • NLSP N/A
  • AHG 281.19
  • 52 Week Low
  • NLSP $1.30
  • AHG $0.74
  • 52 Week High
  • NLSP $15.59
  • AHG $2.35
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 46.61
  • AHG 69.29
  • Support Level
  • NLSP $2.20
  • AHG $1.07
  • Resistance Level
  • NLSP $3.08
  • AHG $2.05
  • Average True Range (ATR)
  • NLSP 0.25
  • AHG 0.16
  • MACD
  • NLSP -0.06
  • AHG 0.06
  • Stochastic Oscillator
  • NLSP 8.40
  • AHG 78.57

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About AHG Akso Health Group ADS

Akso Health Group formerly Xiaobai Maimai Inc is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.

Share on Social Networks: